Status:

COMPLETED

MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiotherapy

Lead Sponsor:

University Health Network, Toronto

Collaborating Sponsors:

U.S. Army Medical Research and Development Command

Princess Margaret Hospital, Canada

Conditions:

Recurrent Prostate Cancer

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

In this study we will test a new procedure to guide needle biopsies into the prostate gland based on MRI. This study will be conducted in patients who may have recurrence of their cancer in the prosta...

Detailed Description

This study involves the technical development and clinical testing of a novel technique for magnetic resonance imaging (MRI) guided prostate biopsy in a 1.5T horizontal bore scanner using a dedicated ...

Eligibility Criteria

Inclusion

  • Biochemical failure \> 18 months after definitive external beam radiotherapy (ASTRO definition - revised version 2006: rise by 2 ng/mL or more above the nadir PSA)
  • PSA \<20 prior to initial course of external beam radiotherapy
  • PSADT \>3 months at failure
  • Age ≥ 18 years
  • ECOG performance status 0 or 1 with \>10 year life expectancy
  • Fit for local anaesthesia
  • Informed consent:

Exclusion

  • Contraindications to MRI
  • Severe claustrophobia
  • Bleeding diathesis and anti-coagulative therapy that cannot be temporarily ceased precluding brachytherapy
  • Previous brachytherapy
  • Active hormonal therapy
  • Radiologic evidence of LN or distant metastases
  • Other urinary or medical conditions deemed by the PI or associates to make the patient ineligible for MRI-guided prostate biopsy.
  • Contraindications to endorectal coil, surgically absent rectum, severe hemorrhoids or previous colorectal surgery
  • Contraindications to conscious sedation
  • Contraindication to IV Gadolinium administration
  • latex allergy

Key Trial Info

Start Date :

October 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 15 2017

Estimated Enrollment :

82 Patients enrolled

Trial Details

Trial ID

NCT00775866

Start Date

October 1 2006

End Date

September 15 2017

Last Update

November 29 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Health Network

Toronto, Ontario, Canada, M5G 2M9